Peptide TherapeuticsPeer Reviewed

Lung tissue-resident memory T cells optimize protection by IL-10 regulation of innate immunity.

Authors (10)
Alexander Y YangDepartment of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA.
Julia Davis-Porada
Daniel H PaikMedical Scientist Training Program, Columbia University Irving Medical Center , New York, NY, USA.
Alex B George
The Journal of experimental medicine
Unknown
Published
Oct 13, 2025
View Original

Abstract

Respiratory viral infections establish tissue-resident memory T cells (TRM) in the lung, which provide optimal protection against subsequent infections, though the underlying mechanisms are incompletely understood. Here, we demonstrate in a mouse model of heterosubtypic influenza infection that lung TRM attenuate inflammation by macrophages during secondary versus primary responses, in part, through production of the immunoregulatory cytokine IL-10. During secondary infections, lung TRM were the predominant producers of early IL-10; inhibiting early IL-10 signaling resulted in increased macrophage-mediated inflammation, morbidity, and lung pathology. Moreover, lung TRM were shown to directly modulate lung macrophage responses and polarization in depletion experiments. Finally, IL-10 enhanced IFN-γ production by lung memory CD8+ T cells. Human influenza-specific TRM isolated from lungs recapitulated robust IL-10 expression associated with augmented effector responses of murine TRM. These data support a dual role of TRM in coordinating in situ secondary responses-augmenting effector responses for robust viral clearance while dampening inflammation to limit tissue damage.

Keywords

AnimalsInterleukin-10LungImmunity, InnateMemory T CellsOrthomyxoviridae InfectionsMice, Inbred C57BLHumansMiceCD8-Positive T-LymphocytesMacrophagesImmunologic MemoryInterferon-gammaFemaleInflammation

Article Metrics

Sourcepubmed

Related Research

Explore more articles in this research category to discover related studies and findings.

View more in Peptide Therapeutics